Leishmaniasis - General Aspects of a Stigmatized Disease [Working Title]最新文献

筛选

英文中文

Use of Cell Biology to Identify Cellular Targets in Drug Development Process against Leishmania Sp. 利用细胞生物学鉴定抗利什曼原虫药物开发过程中的细胞靶点。

Leishmaniasis - General Aspects of a Stigmatized Disease [Working Title] Pub Date : 2021-12-30 DOI: 10.5772/intechopen.101662

Gabrielle dos Santos da Silva e Miranda, Joseane Lima Prado Godinho, Sara Teixeira de Macedo-Silva, Brunno Renato Farias Verçoza, Alisson Amaral da Rocha, Milena Barenco Pires de Abreu Sodré, Victor Feliciano dos Santos Ramos, Juliany Cola Fernandes Rodrigues

{"title":"Use of Cell Biology to Identify Cellular Targets in Drug Development Process against Leishmania Sp.","authors":"Gabrielle dos Santos da Silva e Miranda, Joseane Lima Prado Godinho, Sara Teixeira de Macedo-Silva, Brunno Renato Farias Verçoza, Alisson Amaral da Rocha, Milena Barenco Pires de Abreu Sodré, Victor Feliciano dos Santos Ramos, Juliany Cola Fernandes Rodrigues","doi":"10.5772/intechopen.101662","DOIUrl":"https://doi.org/10.5772/intechopen.101662","url":null,"abstract":"Leishmaniasis is one of the most important neglected tropical diseases. The chemotherapy for its treatment uses very toxic compounds with a low efficacy rate. Thus, there is an urgent need to develop new chemotherapeutic agents to help countries control this devasting disease. In drug development, different approaches can be used to identify potential cellular targets that allow us to understand better the cell biology of eukaryotic cells. Several groups are dedicated to studying new molecules, searching for promising candidates against Leishmania. Different techniques have been used to characterize the cell biology, biochemistry, and molecular biology alterations induced by the treatments, trying to understand the mechanisms of action. The main goal of this chapter is to describe an overview of the literature exploring the several studies published about the chemotherapy of anti-Leishmania concerning the mechanisms of action of different classes of molecules or therapeutic alternatives.","PeriodicalId":120014,"journal":{"name":"Leishmaniasis - General Aspects of a Stigmatized Disease [Working Title]","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122240104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Toward New Antileishmanial Compounds: Molecular Targets for Leishmaniasis Treatment 抗利什曼病新化合物:治疗利什曼病的分子靶点

Leishmaniasis - General Aspects of a Stigmatized Disease [Working Title] Pub Date : 2021-12-04 DOI: 10.5772/intechopen.101132

H. Istanbullu, Gulsah Bayraktar

引用次数: 1